Zhang (5) reported a case of SLE with stage IV diffuse large B cell lymphoma (DLBCL) that achieved stable remission following anti-BCMA/CD19 CAR-T therapy (Figure 2C). Here, TNFRSF17 is linked to diffuse large B-cell lymphoma.